EndoID™ is a first-in-class blood-based ELISA test developed by SYNG Pharmaceuticals Inc. to support non-invasive triage of women suspected of endometriosis. They also have an AI-powered digital cognitive assessment that helps assessment in post-partum depression and depression due to infertility and chronic pain.
